Clinical Spectrum of Neurological Complaints in COVID-19: Experiences from a COVID-19 Referral Hospital in Indonesia

Rocksy Fransisca V. Situmeang, Astra Dea Simanungkalit, Anyeliria Sutanto, Aristo Pangestu

Abstract


Background: The main feature of COVID-19 is symptoms of respiratory system disorder, however, there has been an increase in reports of neurological symptoms that appear in COVID-19 patients. Several previous studies have linked SARS-CoV-2 with nervous system damage. Research studying neurological complaints in  confirmed COVID-19 patients in Indonesia is still lacking

Aim: To identify neurological, laboratory, and imaging findings in COVID-19 patients with neurological symptoms.

Methods: This study was a cross-sectional observational study conducted at Siloam Hospitals Mampang, a COVID-19 referral hospital in South Jakarta. We analyzed medical records of confirmed COVID-19 patients during the period of April - July 2020. The data collected included demographic data, comorbidities, neurological manifestations, laboratory examinations, and neuroimaging.

Results: There were 22 confirmed COVID-19 patients with neurological complaints referred to a neurologist. The mean age of patients was 60.4 (SD 15.8) years. The most common neurological complaints were altered mental status (50%), hemiparesis (27.3%), and tremors (22.7%). More than half of the patients (81.8%) had a comorbid condition or past history related to neurological symptoms. Laboratory examination results showed increased NLR (neutrophil-lymphocyte ratio) (50%), anemia (45.5%), and leukocytosis (40.1%). The most common neuroimaging feature was infarct (50%) in the brain CT scan.

Conclusion: The neurological complaints in COVID-19 patients are mostly associated with exacerbation of pre-existing comorbidities as a result of the severe inflammatory process triggered by COVID-19. Further research is needed to establish the mechanism of nervous system dysfunction in COVID-19.


Keywords


COVID-19; neurological complaint; neurological complication; Neurological manifestation; SARS-CoV-2



DOI: http://dx.doi.org/10.19166/med.v9i1.4195

Full Text:

PDF

References


1. Pinna P, Grewal P, Hall JP, Tavarez T, Dafer RM, Garg R. Neurological manifestations and COVID-19: Experiences from a tertiary care center at the Frontline. Journal of Neurological Sciences 2020 415;116969
https://doi.org/10.1016/j.jns.2020.116969

2. World Health Organization Coronavirus Disease (COVID-19), Situation Report- 117, Accessed May 16, 2020, https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200516-covid-19-sitrep-117.pdf?sfvrsn=8f562cc_2

3. Astuti I, Ysrafil. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab Syndr. 2020; 14(4): 407-412.
https://doi.org/10.1016/j.dsx.2020.04.020

4. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.
https://doi.org/10.1016/S0140-6736(20)30183-5

5. Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, et al. COVID‐19 diagnosis and management: a comprehensive review. J Intern Med 2020; 288: 192- 206.
https://doi.org/10.1111/joim.13091

6. Chen N, Zhou M, Dong X et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.The Lancet 2020; 395: 507-13.
https://doi.org/10.1016/S0140-6736(20)30211-7

7. Yang J, Zheng Y, Gou X et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID‐19) infection: a systematic review and meta‐analysis. International Journal of infectious diseases. IJID 2020; 94: 91-5.
https://doi.org/10.1016/j.ijid.2020.03.017

8. Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. Lancet Neurol 2020;
https://doi.org/10.2139/ssrn.3589350

9. Nepal G, Rehrig JH, Shrestha GS, Shing YW, Yadav JK, Ojha R, et al. Neurological manifestations of COVID-19: a systematic review. Crit Care 24, 421 (2020).
https://doi.org/10.1186/s13054-020-03121-z

10. Helms J, Kremer S, Merdji, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020; 382:2268-2270.
https://doi.org/10.1056/NEJMc2008597

11. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanism. ACS Chem Neurosci 2020; 11(7):995-998.
https://doi.org/10.1021/acschemneuro.0c00122

12. Abboud H, Abboud FZ, Kharbouch H, Arkham Y, El Abbadi N, El Ouahabi A. COVID-19, and SARS-CoV-2 infection: pathophysiology and clinical effects on the nervous system. World Neurosurg 2020; 140:49-53.
https://doi.org/10.1016/j.wneu.2020.05.193

13. Mondal R, Ganguly U, Deb S, Shome G, Pramanik S, Bandyopadhyay D, et al. Meningoencephalitis associated with COVID-19: A systematic review. J Neurovirol. 2021 Feb;27(1):12-25. https://doi.org/10.1007/s13365-020-00923-3

14. Majid F, Ali M, Somayeh M, Cyrus R. Neurobiology of COVID-19. Journal of Alzheimer's Disease 2020; 76:3-19.
https://doi.org/10.3233/JAD-200581

15. Pilotto A, Odolini S, Masciocchi S, Comelli A, Volonghi I, Gazzina S, et al. Steroid-Responsive Encephalitis in Coronavirus Disease 2019. Annals of Neurology 2020;
https://doi.org/10.1101/2020.04.12.20062646

16. Panariello A, Bassetti R, Radice A, Rossotti R, Puoti M, Corradin M, et al. Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: A case report. Brain, Behaviour, and Immunity 2020; 87:179-181.
https://doi.org/10.1016/j.bbi.2020.05.054

17. Dogan L, Kaya D, Sarikaya T, Zengin R, Dincer A, Ozkan I, et al. Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: Case series. Brain, Behavior, and Immunity 2020; 87: 155-158.
https://doi.org/10.1016/j.bbi.2020.05.022

18. Dellamare L, Gullion CM, Grouteau G, Rousset D, Jimena G, Roustan J. COVID-18-associated acute necrotizing encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fiber network. J Neurol Neurosurg Psychiatry 2020.
https://doi.org/10.1136/jnnp-2020-323678

19. Zambreanu L, Lightbody S, Bhandari M, Hoskote C, Kandil H, Houlihan CF, et al. A case of limbic encephalitis associated with asymptomatic COVID-19 infection. J Neurol Neurosurg Psychiatry 2020.
https://doi.org/10.1136/jnnp-2020-323839

20. Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: A case report. J Clin Neurosci 2020; 76:233-235.
https://doi.org/10.1016/j.jocn.2020.04.062

21. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurology 2020; 77(6):683-690.
https://doi.org/10.1001/jamaneurol.2020.1127

22. Divani AA, Andalib S, Di Napoli M, Seletska A, Mayer SA, Torbey M, et al. Coronavirus Disease 2019 and stroke: clinical manifestation and pathophysiological insight. Journal of Stroke and Cerebrovascular Disease 2020; 29(8): 104941.
https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104941

23. Levi M, Toh H, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol. 2009; 145: 24-33
https://doi.org/10.1111/j.1365-2141.2009.07600.x

24. Cavezzi A, Troiani E, Corrao S. COVID-19: hemoglobin, iron, and hypoxia beyond inflammation A narrative review. Clin Pract 2020; 10(2): 1271.
https://doi.org/10.4081/cp.2020.1271

25. Wenzhong L, Hualan L. COVID-19: Attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism. ChemRxiv 2020. Preprint.
https://doi.org/10.26434/chemrxiv.11938173.v8

26. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endothelium in COVID-19. Lancet2020;395: 1417-8.
https://doi.org/10.1016/S0140-6736(20)30937-5

27. Lazarian G, Quinquenel A, Bellal M, Siavellis J, Jacquy C, Re D, et al. Autoimmune hemolytic anemia associated with COVID-19 infection. British Journal of Haematology 2020; 290 (1): 29-31.
https://doi.org/10.1111/bjh.16794

28. Hindilerden F, Yonal-Hindilerden I, Akar E, Yesilbag Z, Kart-Yasar K. Severe Autoimmune Hemolytic Anemia in COVID-19 İnfection, Safely Treated with Steroids. Mediterr J Hematol Infect Dis. 2020;12(1):e2020053.
https://doi.org/10.4084/mjhid.2020.053

29. Kubo S, Hosomi N, Hara N, Neshige S, Himeno T, Takeshima S, et al. Ischemic stroke mortality is more strongly associated with anemia on admission than with underweight status. Journal of Stroke and Cerebrovascular Disease 2017; 26(6): 1369-1374.
https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.02.016

30. Yan, X, Li, F, Wang, X, et al. Neutrophil to lymphocyte ratio as a prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross‐sectional study. J Med Virol. 2020; 1- 9.
https://doi.org/10.1002/jmv.26061

31. Didangelos A. 2020. COVID-19 hyper inflammation: what about neutrophils? mSphere 5:e00367-20.
https://doi.org/10.1128/mSphere.00367-20

32. Gralinski LE, Sheahan TP, Morrison TE, Menachery VD, Jensen K, Leist SR, Whitmore A, Heise MT, Baric RS. 2018. Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. mBio 9:e01753-18.
https://doi.org/10.1128/mBio.01753-18

33. Huang I, Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. Journal of Intensive care 2020; 8(36):1-10.
https://doi.org/10.1186/s40560-020-00453-4

34. Li T, Qiu Z, Zhang L, Han Y, He W, Liu Z, et al. Significant changes of peripheral T lymphocyte subsets in patients with the severe acute respiratory syndrome. J Infect Dis. 2004;189:648-51.
https://doi.org/10.1086/381535

35. Lippi, G., South, A. M., & Henry, B. M. (2020). Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Annals of Clinical Biochemistry, 57(3), 262-265.
https://doi.org/10.1177/0004563220922255

36. Habib MB, Sardar S, Sajid J. Acute symptomatic hyponatremia in setting of SIADH as an isolated presentation of COVID-19. ID cases. 2020;21:e00859.
https://doi.org/10.1016/j.idcr.2020.e00859

37. Berni A, Malandrino D, Parenti G, Maggi M, Poggesi L, Peri A. Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together?. J Endocrinol Invest. 2020;43(8):1137-1139.
https://doi.org/10.1007/s40618-020-01301-w

38. Chen, D, Li, X, Song, Q, et al. Hypokalemia and clinical implications in patients with coronavirus disease 2019 (COVID-19). medRxiv. Epub ahead of print 29 February 2020.
https://doi.org/10.1101/2020.02.27.20028530

39. Pan, L, Mu, M, Yang, P, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020; 115: 766-773.
https://doi.org/10.14309/ajg.0000000000000620

40. Song P, Li W, Xie J, Hou Y, You C. Cytokine storm induced by SARS-CoV-2. Clin Chim Acta 2020; 509:280-287.
https://doi.org/10.1016/j.cca.2020.06.017

41. Wu D, Yang XO. TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor. Journal of Microbiology, Immunology, and Infection 2020; 53(3):368-370.
https://doi.org/10.1016/j.jmii.2020.03.005

42. Sarfo FS, Mensah NO, Opoku FA, Adusei-Mensah N, Ampofo M, Ovbiagele B. COVID-19 and stroke: Experience in a Ghanaian healthcare system [published online ahead of print, 2020 Jul 16]. J Neurol Sci. 2020; 416:117044.
https://doi.org/10.1016/j.jns.2020.117044

43. Lu Y, Li X, Geng D, Mei N, Wu P, Huang C, et al. Cerebral microstructural changes in COVID-19 patients-An-MRI-based 3-month follow up study. E Clinical Medicine 2020; 100484.
https://doi.org/10.1016/j.eclinm.2020.100484



Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 Rocksy Fransisca V. Situmeang, Astra Dea Simanungkalit, Anyeliria Sutanto, Aristo Pangestu

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

favicon Fakultas Kedokteran | Universitas Pelita Harapan | Lippo Karawaci, Tangerang, Indonesia, 15811